Showing results (211-220 of 279) with videos related to
Sort By:
Pageof 28
Bone Marrow Transplantation|April 16, 2013
Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDSM Robin, R Porcher, L Adès, et al.Cytotherapy|September 6, 2007
Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 graftsV Vanneaux, E Foïs, M Robin, et al.Bone Marrow Transplantation|March 12, 2014
Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)X Cahu, P Chevallier, A Clavert, et al.Bone Marrow Transplantation|September 23, 2014
Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AMLM Sébert, R Porcher, M Robin, et al.Plant Biology (Stuttgart, Germany)|March 31, 2022
Seasonal shifts in isoprenoid emission composition from three hyperdominant tree species in central AmazoniaE Gomes Alves, T Taylor, M Robin, et al.Bone Marrow Transplantation|December 5, 2012
Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMTR Martino, L de Wreede, M Fiocco, et al.Bone Marrow Transplantation|February 21, 2017
Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TCL Magro, J Gauthier, M Richet, et al.Leukemia|July 24, 2012
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblingsN Kröger, T Zabelina, L de Wreede, et al.Journal of Neuro-Oncology|January 19, 2024
Laser interstitial thermal therapy for deep-seated perivascular brain tumors is not associated with distal ischemiaJared C Reese, Hassan A Fadel, Jacob A Pawloski, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcomeN Penel, A Italiano, I Ray-Coquard, et al.Pageof 28